Clinical & Pharmaceutical Solutions through Analysis
July 29 - 30, 2014
Club Transatlântico, São Paulo
Where Technology and Solutions Meet!
CPSA Brasil 2014
Emerging Models for Drug Development and the Clinical Laboratory: Innovative Technologies and Future Applications
2014 Plenary Speaker
Randall Nelson, Ph.D.
Dr. Nelson received his B.S. degree in Chemistry from Eastern Oregon State College in 1986 and his Ph.D. in Chemistry from Arizona State University in 1990. Dr. Nelson directs the Molecular Biosignatures Analysis Unit within the Biodesign Institute at Arizona State University, and also holds the positions of Research Professor in Biodesign and Affiliate Professor in the Dept. of Chemistry & Biochemistry. Dr. Nelson's research team strives to improve human health and contribute to the vision of personalized medicine by understanding protein differences involved in healthy versus ill individuals. It does this using novel proteomics and mass spectrometric technology and methods. Dr. Nelson's research is currently focused on cancer, cardiovascular disease, and diabetes. Dr. Nelson has published more than 100 peer-reviewed manuscripts regarding biological mass spectrometry and proteomics, and is inventor or co-inventor on 25 issued and 20 pending patents covering mass spectrometric technologies and methods. Prior to coming to ASU, Dr. Nelson founded and, for ten years, served as President and CEO of Intrinsic Bioprobes, Inc., a company in Tempe, AZ that provides protein analysis services.